DNP-CONJUGATED AUTOLOGOUS OVARIAN TUMOR CELL VACCINE ANTIGEN

Substance Class	Structurally Diverse Created by `admin` on `Sat Dec 16 18:47:43 GMT 2023` Edited by `admin` on `Sat Dec 16 18:47:43 GMT 2023`
Source Materials Class	ORGANISM
Source Materials Type	AUTOLOGOUS HUMAN
Source Materials State	KILLED
Source Materials Parent	`G0T704E6Z3` HOMO SAPIENS WHOLE
Part	OVARY
Fraction Material Type	CELL LYSATE
Fraction Name	OVARIAN TUMOR CELLS
Record UNII	BN3JS9QV8E
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

Common Name

English

OVAX

Brand Name

English

DNP-MODIFIED AUTOLOGOUS OVARIAN TUMOR CELLS

Common Name

English

Code System Code Type Description

FDA UNII

BN3JS9QV8E

Created by admin on Sat Dec 16 18:47:43 GMT 2023 , Edited by admin on Sat Dec 16 18:47:43 GMT 2023

PRIMARY

Related Record Type Details


					G59THN8XA6

TARGET->VACCINE ANTIGEN

Amount:

Related Record Type Details


					BN3JS9QV8E

ACTIVE MOIETY

Amount:

Modification Process	Modification Role	Modification Type	Amount	Fragment Name	Fragment ID
HAPTENIZATION	ANTIGEN	IMMUNOLOGICAL		1-FLUORO-2,4-DINITROBENZENE	D241E059U6

Modification Role	Parameter Name	Amount
Sterilization	IRRADIATION

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO_ACID_SUBSTITUTION		N-TERMINUS			DNP-GLYCINE	N78T3J8FGK
AMINO ACID REMOVAL			LYSINE		DNP-L-LYSINE	S6TD66F98C